Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015 Feb;11(2):98-110. doi: 10.1038/nrneurol.2014.252. Epub 2015 Jan 13. Review.
Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson's disease rehabilitation. Neurosci Biobehav Rev. 2018 Jul;90:294-308. doi: 10.1016/j.neubiorev.2018.05.007. Epub 2018 May 4. Review.
Franchignoni F, Horak F, Godi M, Nardone A, Giordano A Using psychometric techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. J Rehabil Med. 2010 Apr;42(4):323-31. doi: 10.2340/16501977-0537.
Grobbelaar R, Venter R, Welman KE Backward compared to forward over ground gait retraining have additional benefits for gait in individuals with mild to moderate Parkinson's disease: A randomized controlled trial. Gait Posture. 2017 Oct;58:294-299. doi: 10.1016/j.gaitpost.2017.08.019. Epub 2017 Aug 18.
HAMILTON M The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5.
Lamont RM, Daniel HL, Payne CL, Brauer SG Accuracy of wearable physical activity trackers in people with Parkinson's disease. Gait Posture. 2018 Jun;63:104-108. doi: 10.1016/j.gaitpost.2018.04.034. Epub 2018 Apr 24.
Leddy AL, Crowner BE, Earhart GM Utility of the Mini-BESTest, BESTest, and BESTest sections for balance assessments in individuals with Parkinson disease. J Neurol Phys Ther. 2011 Jun;35(2):90-7. doi: 10.1097/NPT.0b013e31821a620c.
Lindholm B, Hagell P, Hansson O, Nilsson MH Prediction of falls and/or near falls in people with mild Parkinson's disease. PLoS One. 2015 Jan 30;10(1):e0117018. doi: 10.1371/journal.pone.0117018. eCollection 2015.
Lozano AM, Dostrovsky J, Chen R, Ashby P Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol. 2002 Aug;1(4):225-31. Review.
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995 Jun;4(3):241-8.
Pohl P, Nordin E, Lundquist A, Bergström U, Lundin-Olsson L Community-dwelling older people with an injurious fall are likely to sustain new injurious falls within 5 years--a prospective long-term follow-up study. BMC Geriatr. 2014 Nov 18;14:120. doi: 10.1186/1471-2318-14-120.
Pradhan S, Kelly VE Quantifying physical activity in early Parkinson disease using a commercial activity monitor. Parkinsonism Relat Disord. 2019 Sep;66:171-175. doi: 10.1016/j.parkreldis.2019.08.001. Epub 2019 Aug 3.
Rochester L, Chastin SF, Lord S, Baker K, Burn DJ Understanding the impact of deep brain stimulation on ambulatory activity in advanced Parkinson's disease. J Neurol. 2012 Jun;259(6):1081-6. doi: 10.1007/s00415-011-6301-9. Epub 2011 Nov 16.
Shen X, Mak MK Repetitive step training with preparatory signals improves stability limits in patients with Parkinson's disease. J Rehabil Med. 2012 Nov;44(11):944-9. doi: 10.2340/16501977-1056.
Shen X, Mak MK Technology-assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12-month follow-up. Neurorehabil Neural Repair. 2015 Feb;29(2):103-11. doi: 10.1177/1545968314537559. Epub 2014 Jun 24.
Stack E, Ashburn A Fall events described by people with Parkinson's disease: implications for clinical interviewing and the research agenda. Physiother Res Int. 1999;4(3):190-200.
Steffen T, Seney M Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther. 2008 Jun;88(6):733-46. doi: 10.2522/ptj.20070214. Epub 2008 Mar 20. Erratum in: Phys Ther. 2010 Mar;90(3):462.
The prevention of falls in later life A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull. 1987 Apr;34 Suppl 4:1-24.
Tinetti ME, Speechley M, Ginter SF Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988 Dec 29;319(26):1701-7.
Yamada K, Goto S, Hamasaki T, Kuratsu JI Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Acta Neurochir (Wien). 2008 Jan;150(1):15-22; discussion 22. doi: 10.1007/s00701-007-1451-3. Epub 2008 Jan 10.
Zhu L, Duval C, Boissy P, Montero-Odasso M, Zou G, Jog M, Speechley M Comparing GPS-Based Community Mobility Measures with Self-report Assessments in Older Adults with Parkinson's Disease. J Gerontol A Biol Sci Med Sci. 2020 Nov 13;75(12):2361-2370. doi: 10.1093/gerona/glaa012.
Combined Physiotherapy and Deep Brain Stimulation to Improve Independent Community Mobility in Parkinson's Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.